SAT-489 Monitoring hepatic function at 90 days of abstinence predicts recompensation and reduced liver-related mortality in patients with decompensated alcohol-related cirrhosis
Jan Embacher(Medical University of Vienna), Benedikt Hofer(Austrian Academy of Sciences), Benedikt Simbrunner(Medical University of Vienna), Lukas Hartl(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Georg Semmler(University of Southern Denmark), Mattias Mandorfer(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Mathias Jachs(Medical University of Vienna), Christian Sebesta(Donauspital), Lorenz Balcar(Medical University of Vienna), Georg Kramer(Medical University of Vienna), Nina Dominik(Medical University of Vienna), Lukas Parandian, Paul Thöne(Medical University of Vienna)
Cited by 1
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
|Nature Protocols|2015|119